RIGL
Rigel Pharmaceuticals Inc
Price:  
0.93 
USD
Volume:  
1,041,742.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RIGL Relative Valuation

-449.1%
Upside

As of 2024-06-18, the Relative Valuation of Rigel Pharmaceuticals Inc (RIGL) is (3.23) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.93 USD, the upside of Rigel Pharmaceuticals Inc based on Relative Valuation is -449.1%.

The range of the Relative Valuation is (3.38) - (3.25) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 29.9x - 30.4x 30.2x
Forward P/E multiples 25.5x - 28.8x 27.2x
Fair Price (3.38) - (3.25) (3.23)
Upside -464.3% - -450.9% -449.1%
0.93 USD
Stock Price
(3.23) USD
Fair Price

RIGL Relative Valuation - Historical P/E Data

Date P/E
2024-06-17 -8.21
2024-06-14 -8.44
2024-06-13 -8.63
2024-06-12 -8.86
2024-06-11 -9.04
2024-06-10 -9.04
2024-06-07 -8.42
2024-06-06 -8.50
2024-06-05 -8.66
2024-06-04 -8.63
2024-06-03 -8.71
2024-05-31 -8.66
2024-05-30 -8.30
2024-05-29 -8.13
2024-05-28 -8.25
2024-05-24 -8.04
2024-05-23 -8.00
2024-05-22 -8.17
2024-05-21 -8.10
2024-05-20 -8.46
2024-05-17 -8.42
2024-05-16 -8.70
2024-05-15 -8.59
2024-05-14 -8.39
2024-05-13 -8.70
2024-05-10 -8.72
2024-05-09 -9.04
2024-05-08 -8.79
2024-05-07 -10.54
2024-05-06 -10.81
2024-05-03 -10.63
2024-05-02 -10.19
2024-05-01 -9.66
2024-04-30 -9.30
2024-04-29 -9.48
2024-04-26 -9.75
2024-04-25 -9.75
2024-04-24 -9.97
2024-04-23 -10.10
2024-04-22 -10.01
2024-04-19 -9.57
2024-04-18 -9.30
2024-04-17 -9.83
2024-04-16 -10.10
2024-04-15 -10.19
2024-04-12 -10.63
2024-04-11 -10.90
2024-04-10 -10.81
2024-04-09 -11.07
2024-04-08 -11.16